Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „apixaban“
Suchtreffer
Begriffe & Kennungen
Apixaban Accord · 4.5 · After combined administration of enoxaparin (40 mg single dose) with apixaban (5 mg single dose), an additive
Eintrag öffnenApixaban Accord · 4.5 · Anticoagulants, platelet aggregation inhibitors, SSRIs/SNRIs and NSAIDs Due to an increased bleeding risk, con
Eintrag öffnenApixaban Accord · 4.5 · Anticoagulants, platelet aggregation inhibitors, SSRIs/SNRIs and NSAIDs Due to an increased bleeding risk, con
Eintrag öffnenApixaban Accord · 4.5 · Apixaban coadministered with clopidogrel (75 mg once a day) or with the combination of clopidogrel 75 mg and A
Eintrag öffnenApixaban Accord · 4.5 · Apixaban is not recommended for the treatment of DVT and PE in patients receiving concomitant systemic treatme
Eintrag öffnenApixaban Accord · 4.5 · Atenolol Coadministration of a single dose of apixaban (10 mg) and atenolol (100 mg), a common beta-blocker, d
Eintrag öffnenApixaban Accord · 4.5 · Atenolol Coadministration of a single dose of apixaban (10 mg) and atenolol (100 mg), a common beta-blocker, d
Eintrag öffnenApixaban Accord · 4.5 · Despite these findings, there may be individuals with a more pronounced pharmacodynamic response when antiplat
Eintrag öffnenApixaban Accord · 4.5 · Despite these findings, there may be individuals with a more pronounced pharmacodynamic response when antiplat
Eintrag öffnenApixaban Accord · 4.5 · Digoxin Coadministration of apixaban (20 mg once a day) and digoxin (0.25 mg once a day), a P-gp substrate, di
Eintrag öffnenApixaban Accord · 4.5 · Digoxin Coadministration of apixaban (20 mg once a day) and digoxin (0.25 mg once a day), a P-gp substrate, di
Eintrag öffnenApixaban Accord · 4.5 · Effect of apixaban on other medicinal products In vitro apixaban studies showed no inhibitory effect on the ac
Eintrag öffnenApixaban Accord · 4.5 · In studies conducted in healthy subjects, as described below, apixaban did not meaningfully alter the pharmaco
Eintrag öffnenApixaban Accord · 4.5 · In studies conducted in healthy subjects, as described below, apixaban did not meaningfully alter the pharmaco
Eintrag öffnenApixaban Accord · 4.5 · In study CV185325, no clinically important bleeding events were reported in the 12 paediatric patients treated
Eintrag öffnenApixaban Accord · 4.5 · In study CV185325, no clinically important bleeding events were reported in the 12 paediatric patients treated
Eintrag öffnenApixaban Accord · 4.5 · Inducers of CYP3A4 and P-gp Coadministration of apixaban with rifampicin, a strong inducer of both CYP3A4 and
Eintrag öffnenApixaban Accord · 4.5 · Inhibitors of CYP3A4 and P-gp Coadministration of apixaban with ketoconazole (400 mg once a day), a strong inh
Eintrag öffnenApixaban Accord · 4.5 · Inhibitors of CYP3A4 and P-gp Coadministration of apixaban with ketoconazole (400 mg once a day), a strong inh
Eintrag öffnenApixaban Accord · 4.5 · Interaction studies have not been performed in paediatrics.
Eintrag öffnen